Behaviour change:
The key to unlocking potential in rare diseases

Alpharmaxim Healthcare Communications

Rebuilding beliefs, redefining behaviours:
a necessary shift for medical marketing

At the World Orphan Drug Congress 2021 (November 2021), we presented this poster to international healthcare professionals and patient advocates, driving conversations about the urgent need for behavioural science to become an integrated part of the way we approach tailored healthcare communications in rare diseases.

Behaviour Change Infographic

If you are interested in hearing more about this approach to rare disease medical communications, or wider applications in the healthcare sector, get in touch with our team.







We are committed to your privacy. We may use your contact information to provide you with relevant content and product/service information. We will only use it for this purpose. You can unsubscribe from these services at any time.

Talk to us about how we can transform your communications

Why Plain Language Summaries are vital in rare disease communications

Why Plain Language Summaries are vital in rare disease communications

Plain language summaries can translate complex science for different audiences. But what are they, and how do they improve awareness?
What can COVID-19 campaigns tell us about increasing vaccine uptake?

What can COVID-19 campaigns tell us about increasing vaccine uptake?

We examine what lessons we can take from the COVID-19 vaccine campaigns, and how behavioural science insights may help to drive vaccine uptake.
Transforming the rare disease landscape

Transforming the rare disease landscape

Over the coming months, we’ll be looking at how new, tailored approaches to communications could help transform the rare disease landscape.